This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Cardiomatics
FEBRUARY 5, 2025
We are proud to share our latest study, conducted with University Hospital Basel, and published in Diabetes Care. These commonly used anti-inflammatory drugs often cause insulin resistance, high cholesterol, and muscle loss. This is our fourth research project with University Hospital Basel, and we are excited about whats next.
93 
Becker's Hospital Review - Cardiology
DECEMBER 14, 2023
Researchers at UNM School of Medicine have developed a new LDL cholesterol vaccine that is tested on mice and monkeys with positive results.
109 
Becker's Hospital Review - Cardiology
FEBRUARY 20, 2024
Niacin , a common B vitamin once recommended to patients as a way to help lower cholesterol, has been linked to cardiovascular disease, Cleveland Clinic researchers announced Feb.
100 
DAIC
APRIL 6, 2024
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
98 
American College of Cardiology
MARCH 19, 2024
Noel Bairey Merz, MD, FACC, and Vera Bittner, MD, MSPH, FACC, discuss Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries. In this interview, C.
53 
Medical Xpress - Cardiology
FEBRUARY 23, 2024
When people hear about predicting heart disease, most will think of cholesterol levels.
104 
Dr. Malcolm Kendrick
DECEMBER 5, 2024
In my opinion, or should I say ‘allegedly’ what actually happened here was that Barney Calman had heard from various cardiology experts that cholesterol and statin ‘deniers’ were causing people to stop taking their drugs. Sorry, I know the answer to that. What actually happened? Had Barney ever read any of it?
105 
Frontiers in Cardiovascular Medicine
FEBRUARY 6, 2024
Introduction Triglyceride-rich remnant lipoproteins (TRLs) are considered atherogenic due to the presence of remnant cholesterol, which is transported by apolipoprotein B. In clinical practice, the concentration of TRLs can be estimated by calculating remnant cholesterol or non-HDL cholesterol levels. mmol/L, 11.3%
49 
Dr. Paddy Barrett
SEPTEMBER 20, 2024
The fundamental cause of atherosclerosis is when a cholesterol particle crosses into the artery wall from the bloodstream, gets stuck, and sets off an inflammatory process 1. Every cholesterol particle has a protein marker called ApoB on its outside. Every cholesterol particle has a protein marker called ApoB on its outside.
111 
Becker's Hospital Review - Cardiology
FEBRUARY 22, 2024
To reduce this threat, a variety of screenings are used to monitor heart health, including blood tests to check levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and a blood fat called triglycerides.
105 
DAIC
APRIL 7, 2024
It is well known that high levels of low-density lipoprotein (LDL) cholesterol, known as the “bad” cholesterol, heighten cardiovascular risk. In addition, he said, the reduction in levels of apoB is of interest because this protein is found on all of the lipid particles that contribute to cholesterol buildup in the arteries. “If
116 
Becker's Hospital Review - Cardiology
NOVEMBER 17, 2023
Two recent studies have found drugs that can significantly lower genetic cholesterol levels.
40 40 
DAIC
APRIL 6, 2024
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at ACC.24, HDL cholesterol removes cholesterol from the arteries and carries it to the liver, which then excretes it.
78 
DAIC
JANUARY 4, 2024
Building on evidence from several studies that found prolonged fasting may be unnecessary, a randomized, controlled trial at a Midwest heart hospital determined that allowing patients to eat a heart-healthy diet before elective cardiac catheterization posed no safety risk, while improving patient satisfaction and overall care.
105 
DAIC
FEBRUARY 28, 2024
“Untreated risk factors have a larger impact on risk for death following a serious heart event among survivors of childhood cancer relative to the general population, and therefore we shouldn’t just assume that because someone is young they don’t need risk factors like high blood pressure or high cholesterol treated.” and David Doody , M.S.,
105 
Frontiers in Cardiovascular Medicine
DECEMBER 14, 2023
Methods The retrospective study was conducted on 3,201 patients who underwent coronary angiography at the Department of Zhongnan Hospital of Wuhan University. The monocyte to high-density lipoprotein cholesterol ratio (MHR) was identified as a stronger independent risk factor for CHD.
DAIC
APRIL 1, 2024
Sengupta, who is also Chief of Cardiology at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, is the lead author of a paper in The Lancet explaining which technologies are here now and which are coming soon. “It It will be important that we learn and embrace the winds of change that are imminent.”
105 
DAIC
MARCH 31, 2025
Together with statins, antihypertensives, and other standard of care treatments, this anti-inflammatory therapy may become a vital pillar in cardiovascular disease management, and could help reduce hospitalizations and cut long-term healthcare costs.
Dr. Paddy Barrett
JUNE 21, 2024
He had high blood pressure and high cholesterol most of his life, and he wasn’t great at taking his tablets.” Lipoprotein (a) Lipoprotein (a) or Lp(a), pronounced “L P Little A”, is the most common genetic cholesterol particle disorder in the population. “Dad had a heart attack at 78.
DAIC
APRIL 11, 2024
At two years, people who underwent preventive PCI were 89% less likely to experience the composite primary endpoint of cardiac death, heart attack in the target vessel, revascularization due to ischemia in the target vessel or hospitalization for unstable or progressive chest pain compared with people who received medications alone.
111 
Cardiometabolic Health Congress
APRIL 19, 2024
Addressing an Unmet Need in Pediatric Patients with HeFH Heterozygous familial hypercholesterolemia (HeFH) affects about 1 in 313 people—characterized by dangerously high low-density lipoprotein cholesterol (LDL-C) levels. Untreated, it can trigger early heart disease.
52 
DAIC
JANUARY 25, 2024
More than 8 million Americans visit hospital emergency departments experiencing chest pain every year. “In the future, patients with coronary inflammation can be identified by the CaRi-Heart technology and treated by our FDA -approved LODOCO 0.5 mg tablets.”
110 
Dr. Prateek Bhatnagar
JULY 3, 2018
Eat Healthy - Eating foods which are high in minerals, iron, calcium like green leafy vegetables, vegetables, mushrooms & not indulging too much in red meats which increase cholesterol levels is a good habit to make. Regular Tests - Some tests like BP, Sugar, Cholesterol should be done so you know what condition your health is in.
52 
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
There were no significant difference between the two groups in terms of age, gender, body mass index (BMI), left ventricular ejection fraction(LVEF), low-density lipoprotein cholesterol(LDL-C),cardiovascular risk factors. In Group A, no significant differences in CPET indices were observed before and after the intervention.
64 
Journal of the American Heart Association
DECEMBER 19, 2024
BackgroundElevated lowdensity lipoprotein cholesterol is a risk factor for atherosclerotic cardiovascular disease, including acute ischemic stroke (AIS), due to large and smallvessel disease. Cholesterol management guidelines recommend lipidlowering therapy (LLT) to prevent atherosclerotic cardiovascular disease events.
40 
Frontiers in Cardiovascular Medicine
APRIL 24, 2024
More specifically, recurrent AF patients are significantly younger and have better baseline health, in terms of reduced cholesterol and blood pressure, than single AF patients. However, this approach lacks granularity, thus overlooking subtleties within patient populations.
Open Heart
MARCH 30, 2022
Results 2011/2012 patients were older than those diagnosed a decade before, with lower blood pressure and cholesterol but more comorbidity and healthcare contacts. for hospital-diagnosed patients). Survival rates since diagnosis were described using Kaplan-Meier plots. Compliance with national guidelines was summarised.
DAIC
MAY 16, 2024
Risk factors for PAD include smoking; having Type 1 or Type 2 diabetes, high blood pressure, high cholesterol, chronic kidney disease, atherosclerosis in other parts of the body (such as coronary artery disease); and being age 75 years or older. and Global Data From the American Heart Association.
European Journal of Cardiovascular Nursing
JANUARY 27, 2025
We recruited 761 patients hospitalized for HF. Compared with the T1 group, the T3 and T4 groups included more females; were older; had higher natriuretic peptide and glycohaemoglobin levels; and had higher incidences of comorbidities but lower albumin and cholesterol and worse kidney function (all P < 0.05).
40 
Open Heart
MARCH 16, 2023
Comparing baseline to end of programme, we observed significant improvements in the proportion of patients meeting guideline-recommended targets for physical activity (+68%, p<0.001), BP (+44%, p<0.001) and low-density lipoprotein cholesterol (+27%, p<0.001). There were significant reductions in mean weight (–2.6
52 
DAIC
JANUARY 22, 2024
Levine Professor of Medicine at Harvard Medical School , former chair of the department of medicine and physician-in-chief emeritus at Brigham and Women’s Hospital in Boston; Daniel J. Rader , M.D.,
105 
DAIC
JANUARY 23, 2024
Nearly 20% of those people who have had a MI will be hospitalized again within five years due to a second event.5 12,27 In contemporary lipid-lowering trials, there are roughly twice as many individuals in whom the principle unmet clinical need is residual inflammatory risk as compared with residual cholesterol risk.28 4 In the U.S.
Cardiometabolic Health Congress
JANUARY 3, 2024
Tirzepatide In November of 2023, the FDA approved tirzepatide (Zepbound) for chronic weight management in adults with obesity, or who are overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. Furthermore, most of the participants who were given survodutide 3.6 at 36 weeks.
97 
Stroke Journal
JANUARY 30, 2025
Cholesterol control, blood sugar management, tobacco cessation, and blood pressure management were chosen using the American Heart Associations Lifes Crucial 9 for their Medicare coding availability. Index hospitalization and post-acute care utilization, including hospital readmission, appeared lower in MA.
40 
Dr. Malcolm Kendrick
OCTOBER 20, 2023
People at risk of cardiovascular disease would have their cholesterol levels checked. We know that lowering blood pressure is highly beneficial, as is lowering cholesterol and blood sugar levels. 3 My main current job involves working in a unit looking after elderly people who, for one reason or another have ended up in hospital.
52 
Stroke Journal
FEBRUARY 1, 2024
This association remains independent even after adjustment for factors such as statin use or low-density lipoprotein cholesterol (LDL-C) levels. Lp(a) levels were categorized into two groups: below 50 mg/dl and 50 mg/dl or higher. Carotid ultrasound results were divided into two groups based on the presence or absence of plaque.
40 Journal of the American Heart Association
JANUARY 16, 2024
Key secondary and exploratory outcomes include improvement in a composite cardiovascular health metric, CR engagement, quality of life, health factors (including low‐density lipoprotein‐cholesterol, hemoglobin A1c, weight, diet, smoking cessation, blood pressure), and psychosocial factors.
DAIC
MARCH 31, 2025
Together with statins, antihypertensives, and other standard of care treatments, this anti-inflammatory therapy may become a vital pillar in cardiovascular disease management, and could help reduce hospitalizations and cut long-term healthcare costs.
Wellnest
DECEMBER 21, 2022
Patients use them to observe their heart activity by themselves when they are not in the hospital. Though their accuracy is not as high as a hospital ECG machine, they are very beneficial in detecting problems in any medical emergency and providing information about long-term heart activity.
SoftCath
OCTOBER 31, 2021
For this reason, the management of cardiac patients in the hospital environment has proven to be a real, enormous challenge during and after the pandemic. This service allows the individual to monitor and diagnose the cardiac care needed by them, visiting no hospital. For example, Zio service by iRhythm.
52 
Dr. Sanjay Gupta
DECEMBER 19, 2022
With time, fat and cholesterol can get trapped in the areas of wear and tear and cause plaque formation. As many heart rhythm disturbances terminate by the time that the patient makes it to hospital, prolonged heart monitoring is often required to capture the heart rhythm disturbance. The plaques can damage us in 2 ways.
40 
Dr. Anish Koka
JANUARY 18, 2023
Discovering discrepancies in a major published trial from the pharma-academic complex would be a boost to those seeking to force trial data to be public, and that is exactly what a group of investigators attempted to do with a major cholesterol lowering trial published in 2017. Cholesterol lowering is big business. billion dollars.
52 
Dr. Paddy Barrett
AUGUST 15, 2023
mmol/l (150 mg/dl) Low HDL Cholesterol - (Males: <1.0 Assessing fasting insulin can be tricky and often needs to be done in a major hospital lab setting. Just as you would get your cholesterol or your blood pressure checked as part of a health evaluation, an assessment of insulin resistance should also be included.
Dr. Sanjay Gupta
DECEMBER 19, 2022
It is also very important to mention a history of high blood pressure, diabetes, elevated cholesterol, family history of premature heart disease, stroke or even sudden death. All patients should have a 12 lead ECG and be put on a 24 hour heart monitor whilst in hospital. When AF is seen, it leads to a change in management.
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content